The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 03, 2018
Filed:
Mar. 28, 2017
Applicants:
Marc Cox, El Paso, TX (US);
Huan Xie, Houston, TX (US);
Oscar Ekpenyong, Houston, TX (US);
Inventors:
Assignees:
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, Austin, TX (US);
TEXAS SOUTHERN UNIVERSITY, Houston, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4184 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 9/08 (2006.01); G01N 33/487 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 9/1271 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); G01N 33/487 (2013.01);
Abstract
Certain embodiments are directed to a GMC1 co-solvent formulation. The GMC1 co-solvent formulation described herein can be used for the treatment of prostate cancer, benign prostatic hypertrophy, and other hormone-related conditions involving androgen, glucocorticoid, and progesterone receptors.